You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 April 2025 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) announced on Tuesday that an independent Data Safety Monitoring Board has recommended the continuation of its Phase 2b PHOEBUS trial evaluating MaaT033, following a...
8 April 2025 - Medtech company Xeltis, a developer of implants designed to enable the natural creation of living and long-lasting vessels, announced on Tuesday that it has successfully passed the evaluation phase of the 2025 European Innovation Counc...
8 April 2025 - US biopharmaceutical company Halozyme Therapeutics Inc (NASDAQ: HALO) announced on Monday that Janssen-Cilag International NV, part of Johnson & Johnson (J&J) (NYSE:JNJ), has received European Commission marketing authorisation...
7 April 2025 - Cancer diagnostics company NeoGenomics Inc (NASDAQ:NEO) confirmed on Monday that it has completed its acquisition of Pathline LLC, a laboratory in New Jersey.This acquisition enhances NeoGenomics' commercial presence in the Northe...
7 April 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Monday that it has obtained CE-marking for LUMED APSS, a clinical decision support system designed to enhance antimicrobial stewardship programmes and impro...
3 April 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that the US Food and Drug Administration has granted orphan drug designation to rilzabrutinib for warm autoimmune haemolytic anaemia (wAIHA) ...
3 April 2025 - Biotechnology company Circio Holding ASA (OSE:CRNA) and Entos Pharmaceuticals U.K. Ltd, a clinical-stage genetic medicines company, on Thursday announced a research collaboration to advance circular RNA delivery technology.This partner...